Today in Peak History (March 1-March 10)
Release time:
2020-08-14
peak (3# March 1 - 3# July 10 )
1958 3 , Zhejiang Provincial Planning Commission decided to build a cement plant with an annual output of 3.2 tons in Jinhua.
1959 3 , Jinhua county party Committee approved Jinhua cement factory to establish a party branch, with sun zhenzhi as party branch secretary and factory director.
1961 3 , Jinhua county party Committee decided to suspend Jinhua cement factory according to the spirit of the provincial planning Committee document. except for leaving 3 employees to take care of the factory equipment, the rest of the cadres and employees were transferred or streamlined and decentralized one after another.
1979 3 In January, Zhejiang Revolutionary Committee of Zhejiang Provincial Committee named Jinhua Cement Factory as "Daqing-style Enterprise in Zhejiang Province".
1986 3# In August, Jinhua Cement Factory founded the Publicity Monthly.
3 4 , Zhejiang Film Studio came to Jinhua Cement Factory to shoot a documentary on "The Rise of the Peak. ◆
3 April 9 , the CPC Jinhua Municipal Committee approved the establishment of the CPC Zhejiang Jianfeng Group Co., Ltd. committee, with Xu Zeng as party secretary. ◆
3 In early March, the second monthly edition of 8 4 was set up to print "Peak Newspaper". ◆
3# In early April, Jianfeng Group was identified as a pilot unit for the conversion of enterprise management mechanism in Zhejiang Province. ◆ 1993
3 January 1 , Zhejiang Provincial Planning and Economic Commission and Zhejiang Provincial System Reform Commission jointly approved that Zhejiang Jianfeng Building Materials Group was renamed "Zhejiang Jianfeng Group" and upgraded to a provincial enterprise group. Zhejiang Jianfeng Building Materials Group Co., Ltd. was also renamed "Zhejiang Jianfeng Group Co., Ltd". 1998
3 1 , Jianfeng Group took a stake in Tianjin Tianshili Pharmaceutical Group Company. ◆ 2006
3 , Zhejiang Jianfeng International Trading Company passed the comprehensive evaluation of comprehensive service logistics enterprise AA , becoming the first enterprise in Jinhua City to pass the evaluation. ◆ 2010
3# November and August, Renshoutang Pharmacy of Jianfeng Pharmacy was named "Top Ten Outstanding Historical Buildings in Jinhua City". ◆ 2011
◆ 2013 3
4 , Jianfeng Pharmaceutical became the "double-qualified" education and training base in higher vocational colleges nationwide. ◆ 2014 3# In January, Jianfeng Pharmaceutical was selected as "
China Pharmaceutical Annual Power List-Top Ten Most Growing Enterprises in China Pharmaceutical Industry". ◆ 2016 3 months, daye peak cement company trade union was awarded the "provincial model worker's home" medal by Hubei provincial Federation of trade unions.
◆ 2016 3 July, Jianfeng Pharmacy Renshou Hall was awarded the second batch of Zhejiang Province "Gold Medal Time-honored Brand".
◆ 2016 3 April
day, peak health technology company "Shenyang pharmaceutical university professional degree master's degree practice base" was unveiled. ◆ 2017 3 March, the clinical application of the national class I new drug
(deoxypodophyllotoxin) of Jianfeng Pharmaceutical was approved by the State Food and Drug Administration. (Xu Xia finishing)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31